Development, Characterization and Pharmacokinetic Profile of Chitosan-Sodium Tripolyphosphate Nanoparticles Based Drug Delivery Systems for Curcumin

Wawaimuli Arozal ¹ , Melva Louisa ¹ , Deni Rahmat ² , Priska Chendrana ², Ni Made Dwi Sandhiutami ^2,3 *

Cited by CrossRef: 7

1- Singh C, Rai P, Kumar M, Tiwari V, Tiwari A, Sharma A, Sharma K. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics. PNT. 2024;12(2):126 [Crossref]

2- Louisa M, Wanafri E, Arozal W, Sandhiutami N, Basalamah A. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats. Pharmaceutical Biology. 2023;61(1):298 [Crossref]

3- Li C, Naeem A, Shen J, Zha W, Zeng Q, Zhang P, Li L, Liao Z, Chen X. Advances in the pharmaceutical research of curcumin for oral administration. 2023;21(1) [Crossref]

4- Sable A, Kunwar A, Barik A. Alginate and Chitosan-Based Delivery Systems for Improving the Bioavailability and Therapeutic Efficacy of Curcumin. Pharmaceutics. 2024;16(3):423 [Crossref]

5- Zandieh M, Farahani M, Daryab M, Motahari A, Gholami S, Salmani F, Karimi F, Samaei S, Rezaee A, Rahmanian P, Khorrami R, Salimimoghadam S, Nabavi N, Zou R, Sethi G, Rashidi M, Hushmandi K. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy. Biomedicine & Pharmacotherapy. 2023;166:115283 [Crossref]

6- Sandhiutami N, Dewi R, Khairani S, Putri R. Enhancement of curcumin level and hepatoprotective effect in rats through antioxidant activity following modification into nanosized particles. Vet World. 2022;:2323 [Crossref]

7- Sandhiutami N, Arozal W, Louisa M, Rahmat D, Wuyung P. Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA. Front Pharmacol. 2021;11 [Crossref]

8- Kim E, Baek Y, Yoo H, Lee J, Lee H. Chitosan-Tripolyphosphate Nanoparticles Prepared by Ionic Gelation Improve the Antioxidant Activities of Astaxanthin in the In Vitro and In Vivo Model. Antioxidants. 2022;11(3):479 [Crossref]

9- Weng J, Durand A, Desobry S. Chitosan-Based Particulate Carriers: Structure, Production and Corresponding Controlled Release. Pharmaceutics. 2023;15(5):1455 [Crossref]

10- Padalkar R, Madgulkar A, Mate R, Pawar A, Shinde A, Lohakare S. Investigation of curcumin nanoparticles and D –panthenol for diabetic wound healing in wistar rats: Formulation, statistical optimization and in-vivo evaluation. Journal of Drug Delivery Science and Technology. 2024;93:105390 [Crossref]

11- Mohtashami L, Shakeri A, Javadi B. Bioactive natural products against experimental autoimmune encephalomyelitis: A pharmacokinetics review. Physiol Pharmacol. 2021;0(Accepted Manuscripts):0 [Crossref]